Brief: Pharma Mar Signs Agreement With Valeo Pharma To Commercialize Yondelis In Canada

Valeo Pharma

21/01/2020 07:18

Jan 21 (Reuters) - Pharma Mar SA  PHMR.MC :
    * PHARMA MAR SA SAYS SIGNS AGREEMENT WITH VALEO PHARMA TO
COMMERCIALIZE YONDELIS IN CANADA
    * PHARMA MAR SA - IT WILL RECEIVE NON-DISCLOSED UPFRONT
PAYMENT
AND WILL BE ELIGIBLE FOR ADDITIONAL REMUNERATIONS, INCLUDING
REGULATORY MILESTONE PAYMENTS
    * PHARMA MAR SA - IT WILL RETAIN EXCLUSIVE PRODUCTION RIGHTS
OF
PRODUCT AND WILL SELL PRODUCT TO VALEO PHARMA FOR ITS CLINICAL
AND COMMERCIAL USE

Source text: https://bit.ly/2G7PMsV
    
Further company coverage:  PHMR.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))